Posted by Michael Wonder on 13 Nov 2020
EU secures 300 million doses of BioNTech, Pfizer’s COVID-19 vaccine
13 November 2020 - The European Commission has secured a supply deal with BioNTech and Pfizer for 300 million doses of their COVID-19 vaccine candidate.
This includes an initial order for 200 million doses for all EU Member States, as well as an additional option to purchase another 100 million doses of the vaccine if it is proven to be safe and effective against COVID-19.
